Each of us can make a difference in the lives of others through participation in a clinical trial. Researchers are working hard to identify the particular characteristics of the enormously varied range of diseases that fall under the term neuroendocrine tumors or neuroendocrine cancer.
THE NET TRIAL FINDER
The NorCal CarciNET Community funded the development of a trial finder for neuroendocrine cancer research in partnership with Ancora.ai, a health tech company on a mission to help all cancer patients access clinical trials.
Clinical trials are often the best (sometimes only) treatment option for neuroendocrine tumors (NETs) due to rapidly evolving research in the space. However, identifying the right clinical trial is a tedious task even for specialist physicians, and a nearly impossible one for patients. The free, online tool offers personalized, unbiased trial results. It is currently being deployed with medical and patient organizations globally to further increase access to NET trials.
NET Trial Finder
For questions and more details on the trial finder tool, please contact info@ancora.ai.
“The online NETs trial finder tool is a first-of-its-kind resource for patients and oncologists alike. Finally, we have an easy, but comprehensive tool to quickly identify relevant neuroendocrine tumor trials for a patient in minutes.”
TRIALS TODAY
Thousands of organizations across the country are looking for people to take part in research studies. Trials Today created a search tool to narrow down the thousands of studies available on ClinicalTrials.gov by answering a few short questions.
Trials Today Search Tool
With Researchmatch.ORG, Difficult Diseases Have Met their match
Research Match VOLUNTEER REGISTRY
ResearchMatch is a national registry designed to promote the completion of clinical trials by matching volunteers interested in research with researchers nationwide. Funded by the National Center for Advancing Translation Science, which is part of the NIH, ResearchMatch is disease-neutral and institution-neutral so that participants with and without health problems can be included and valued.
